Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers

Clinical diagnosis of Alzheimer's disease

Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text

Medicine, Geriatric Medicine, Neurology +16

Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo

Randall J. Bateman, Ling Y. Munsell, John C. Morris et al. · Nature Medicine · 2006 · 590 citations · Full text

Life Sciences, Neuroscience, Pharmacokinetics +14

Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan

Mitsuyasu Kanai, E. Matsubara, Kenji Isoe et al. · Annals of Neurology · 1998 · 342 citations

Medicine, Neurology, Neuroscience +17

A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous system

Randall J. Bateman, Eric Siemers, Kwasi G. Mawuenyega et al. · Annals of Neurology · 2009 · 323 citations · Full text

Life Sciences, Neuroscience, Pharmacology +12

The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer’s type

Gerald D. Silverberg, Gary Heit, Stephen L. Huhn et al. · Neurology · 2001 · 277 citations

Medicine, Neurology, Neuroscience +8